- Trip Hofer, VP, Specialty Product, President of Accordant, a CVS Health company
- Theresa Juday, Senior Specialty Professional, Specialty Pharmacy, CVS Health
Applying Innovative Technology to Enhance the Effectiveness of a Specialty Management Model
May 8, 2016, 12:30 - 1:30pm
Presenter: Trip Hofer, VP, Specialty Product, President of Accordant, a CVS Health company
By 2020, specialty drugs will represent 55% of all drug costs, with half falling under the medical benefit. Disparate benefit systems can contribute to limited visibility into a health care payor’s true specialty drug spend, and lead to complex and fragmented care. Using automated technology to manage across medical and pharmacy benefits can help generate incremental savings opportunities while improving patient outcomes. This session will explore how technology can help transform data into actionable interventions to manage the health of complex populations, improve clinical outcomes, and deliver lowest net cost for payors.
Proactive Pipeline Management to Help Address Growing Trend
May 9, 2017, 1:00-2:00 pm
Presenter: Theresa Juday, Senior Specialty Professional, Specialty Pharmacy, CVS Health
With specialty drugs dominating the pipeline for expensive and complex conditions including autoimmune, oncology, cystic fibrosis and even high cholesterol, it is important to have a strong foundational knowledge of the changing market. Some treatment regimens for some of the most expensive specialty drugs cost up to $400,000, while the legal and regulatory treatment of these pricey and often life-saving medications add to management complexity. Learn about key strategies to help mitigate unnecessary drug spend.